Literature DB >> 303245

Evaluation of a standardised assay for the measurement of antibodies to double-stranded (native) DNA.

P Davis, M Burrington, A R Morgan, A Saetre.   

Abstract

A standardised commercially available radioimmunoassay kit for the detection of antibodies to native DNA (N-DNA) has been evaluated in clinical practice. This test system is shown to be a reliably reproducible method of detecting these antibodies. In addition, evaluation of the purity of the radiolabelled test antigen in this assay has shown it to be almost entirely double stranded (native) DNA with virtually no contamination with single stranded (denatured) DNA, and with few areas of single stranded breaks or ends in the duplex molecule. The inclusion of known standards and precise characterisation of the DNA has partially overcome variability in results and provides for interlaboratory standardisation which is lacking in the techniques used at present.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303245      PMCID: PMC476568          DOI: 10.1136/jcp.30.9.827

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  A comparative study of technics for the detection of antibodies to native deoxyribonucleic acid.

Authors:  P Davis; A S Russell; J S Percy
Journal:  Am J Clin Pathol       Date:  1977-04       Impact factor: 2.493

3.  Anti-DNA antibody in procainamide-induced lupus erythematosus. Determinations using DNA fractionated by methylated albumin-Kieselguhr chromatography.

Authors:  J B Winfield; J S Davis
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

4.  Significance of anti-D.N.A. antibodies in systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

5.  Native and denatured DNA, cross-linked and palindromic DNA and circular covalently-closed DNA analysed by a sensitive fluorometric procedure.

Authors:  A R Morgan; D E Pulleyblank
Journal:  Biochem Biophys Res Commun       Date:  1974-11-27       Impact factor: 3.575

6.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

7.  Detection of antibodies to DNA by radioimmunoassay and immunofluorescence.

Authors:  L A Aarden; F Lakmaker; E R de Groot; A J Swaak; T E Feltkamp
Journal:  Scand J Rheumatol Suppl       Date:  1975

8.  Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.

Authors:  J Holian; I D Griffiths; D N Glass; R N Maini; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

9.  Correlation between levels of DNA antibodies and clinical disease activity in SLE.

Authors:  P Davis; J S Percy; A S Russell
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

  9 in total
  3 in total

1.  The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus.

Authors:  E E Okolie; S Shall
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

2.  Seronegative chronic polyarthritis: clinical and serological correlates.

Authors:  J L Rasker; P Davis; P A Bacon
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

3.  Studies on circulating immune complexes of the liver diseases. 5. Anti-DNA antibodies and C1q binding activity.

Authors:  T Arima; J Narumoto; H Shimomura; T Yasuhara; K Kunishi; K Suwaki; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.